Ken Micklethwaite is the Research Group Leader for Cancer Research at the Westmead Institute and is a haematologist and blood and marrow stem cell transplant physician at Westmead Hospital. He is deputy director of the Sydney Cellular Therapies Laboratory, assisting in running the largest stem cell transplant and clinical cell and gene therapy facilities in NSW (as part of the Sydney Cell and Gene Therapy group at Westmead), with an active research interest in immune therapy of infections and cancer.
KeywordsInfection and immunity
ThemesInfection and Immunological Conditions